Intellipharmaceutics International Inc. Quarterly Cash and Cash Equivalents, at Carrying Value in USD from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Intellipharmaceutics International Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2010 to Q1 2023.
  • Intellipharmaceutics International Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending February 28, 2023 was $69.5K, a 67.1% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $69.5K -$142K -67.1% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $83.7K -$688K -89.2% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $79.6K -$1.03M -92.8% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $373K -$2.1M -84.9% May 31, 2022 6-K 2022-07-21
Q1 2022 $211K +$8.7K +4.29% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $772K +$570K +282% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $1.11M +$309K +38.7% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $2.47M +$2.4M +3326% May 31, 2021 6-K 2021-10-15
Q1 2021 $203K +$197K +3249% Feb 28, 2021 6-K 2021-07-15
Q4 2020 $202K +$137K +213% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $799K +$744K +1369% Aug 31, 2020 6-K 2021-10-15
Q2 2020 $72.1K -$958K -93% May 31, 2020 6-K 2021-10-15
Q1 2020 $6.05K -$2.82M -99.8% Feb 29, 2020 6-K 2021-07-15
Q4 2019 $64.6K -$6.58M -99% Nov 30, 2019 6-K 2021-10-15
Q3 2019 $54.4K -$3.03K -5.28% Aug 31, 2019 6-K 2020-10-15
Q2 2019 $1.03M -$330K -24.3% May 31, 2019 6-K 2020-10-15
Q1 2019 $2.82M +$2.55M +944% Feb 28, 2019 6-K 2020-07-15
Q4 2018 $6.64M +$4.74M +250% Nov 30, 2018 20-F 2021-03-31
Q3 2018 $57.4K -$678K -92.2% Aug 31, 2018 6-K 2019-10-11
Q2 2018 $1.36M -$115K -7.79% May 31, 2018 6-K 2019-10-11
Q1 2018 $270K -$2.11M -88.7% Feb 28, 2018 6-K 2019-07-10
Q4 2017 $1.9M -$2.25M -54.2% Nov 30, 2017 20-F 2021-03-31
Q3 2017 $735K Aug 31, 2017 6-K 2018-10-15
Q2 2017 $1.48M May 31, 2017 6-K 2018-10-15
Q1 2017 $2.38M Feb 28, 2017 6-K/A 2018-07-24
Q4 2016 $4.14M +$2.39M +136% Nov 30, 2016 20-F 2020-03-30
Q4 2015 $1.76M -$2.48M -58.5% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $4.23M +$3.47M +457% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $5.6M +$5.09M +987% Feb 28, 2014 6-K 2014-04-14
Q4 2013 $761K +$264K +53% Nov 30, 2013 20-F 2016-03-21
Q1 2013 $516K Feb 28, 2013 6-K 2014-04-14
Q4 2012 $497K -$4.32M -89.7% Nov 30, 2012 20-F 2016-03-21
Q4 2011 $4.82M +$4.03M +510% Nov 30, 2011 20-F 2015-02-27
Q4 2010 $789K Nov 30, 2010 20-F 2014-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.